CARTALAX 20MG

New
CARTALAX 20MG
$65.00 $54.00

Cartalax | 20mg | Synthetic Cytomedin Peptide

For In Vitro Research Use Only — Not for Human or Veterinary Use

Description:

Cartalax is a synthetic cytomedin peptide associated with cartilage- and joint-tissue research. It has been examined in vitro for its potential effects on chondrocyte activity, extracellular matrix stability, collagen regulation, and structural tissue maintenance.

Because of its regulatory properties, Cartalax is commonly used in laboratory environments focused on connective-tissue biology and regenerative cellular processes. Each vial contains 20mg of lyophilized Cartalax peptide for controlled research use.

Specifications:

  • Unit Size: 20mg (lyophilized powder, single vial)
  • Sequence: Proprietary cytomedin peptide sequence
  • Form: Crystalline lyophilized peptide
  • Solubility: Soluble in sterile water or compatible aqueous buffer
  • Storage: Store dry at 2°C–8°C. After reconstitution, refrigerate and use within 10–14 days.

Application Context:

Cartalax is researched in vitro for potential roles in:

  • Chondrocyte regulation and joint-tissue support

  • Extracellular matrix and collagen maintenance

  • Structural-tissue recovery and integrity

  • Cellular regulation of cartilage metabolism

Intended Use:
This compound is intended strictly for in vitro laboratory research. It is not approved for human or animal use and must not be incorporated into food, cosmetics, supplements, or pharmaceuticals.